Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Acer Therapeutics Inc. (ACER)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | | 100.0% | 100.0% | 100.0% | | | | |
| Cost of goods sold | | 206.4% | 0.0% | 1365.7% | | | | |
| Gross profit | | -106.4% | 100.0% | -1265.7% | | | | |
| Selling, general and administrative | | 0.0% | 1365.7% | 0.0% | | | | |
| Research and development | | | | | | | | |
| General and administrative | | 0.0% | | 0.0% | | | | |
| Depreciation | | | | | | | | |
| EBIT | | -206.4% | -1174.6% | -1265.7% | | | | |
| Pre-tax income | | -220.0% | -1220.2% | -1220.2% | | | | |
| Income taxes | | 0.0% | 0.0% | 0.0% | | | | |
| Net income | | -220.0% | -1220.2% | -1220.2% | | | | |
|